Drug Shortage Report for EPINEPHRINE INJECTION USP
| Report ID | 163112 |
| Drug Identification Number | 02435810 |
| Brand name | EPINEPHRINE INJECTION USP |
| Common or Proper name | EPINEPHRINE INJECTION USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | EPINEPHRINE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC |
| Packaging size | 1mL |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-20 |
| Estimated end date | 2022-08-12 |
| Actual end date | 2022-08-15 |
| Shortage status | Resolved |
| Updated date | 2022-08-16 |
| Company comments | Product available at distribution level. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT, SUITE 1050 MISSISSAUGA, ONTARIO CANADA L5R 0G3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-08-16 | French | Compare |
| v6 | 2022-08-16 | English | Compare |
| v5 | 2022-07-11 | French | Compare |
| v4 | 2022-07-11 | English | Compare |
| v3 | 2022-06-21 | English | Compare |
| v2 | 2022-06-20 | French | Compare |
| v1 | 2022-06-20 | English | Compare |
Showing 1 to 7 of 7